News and Announcements
Actinogen Medical Present Xanamem Research at CTAD
- Published December 06, 2016 3:06PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
6th December 2016, ASX Announcement
Actinogen Medical Limited (ASX:ACW) is pleased to announce the presentation of the latest Xanamem™ research data at CTAD (Clinical Trials in Alzheimer’s Disease) in San Diego. The paper: Xanamem™: an 11ß-HSD1 Inhibitor in current development for the management of Alzheimer’s disease (AD), will be presented by Prof Craig Ritchie on Friday the 9th December.
CTAD is one of the most prestigious international Alzheimer’s congresses, where the latest ground-breaking research into Alzheimer’s disease is showcased. CTAD focuses on promising new Alzheimer’s drugs under development. This presentation follows on from the very successful presentations of Xanamem™ at AAIC (Alzheimer’s Association International Congress) in Toronto, ICE (the International Congress of Endocrinology) in Beijing and Mastering Medicinal Chemistry in Lisbon, over the past few months.
To view the full announcement, please click on the button below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
